Biotech Week articles from November 2002

Biotech Week archives from November 2002

Vaccine may be effective with modifications.
November 6, 2002... 2002 NOV 6 - (NewsRx.com & NewsRx.net) -- Trials of a promising new therapy for Alzheimer disease were abruptly halted this year when several of the more than 360 patients enrolled developed inflammation in the brain. But two new studies...

Atorvastatin shown to decrease heart attacks and stroke in certain patients.
November 6, 2002... 2002 NOV 6 - (NewsRx.com & NewsRx.net) -- A major European trial studying different blood pressure treatments and the effects of additional cholesterol lowering, has announced that it has stopped part of its trial earlier than expected because...

Salmonella enterica Typhi vaccine protects against H. pylori infection.
November 6, 2002... 2002 NOV 6 - (NewsRx.com & NewsRx.net) -- by Maria G. Essig, MS, ELS, senior medical writer - Protection against Helicobacter pylori was provided by a vaccination regimen that combined a primary intranasal inoculation with a strain of...

Company receives FDA approval for Versant HIV bDNA viral load system.
November 6, 2002... 2002 NOV 6 - (NewsRx.com & NewsRx.net) -- Bayer Diagnostics announced that it received U.S. Food and Drug Administration approval for Versant HIV-1 RNA 3.0 Assay (bDNA), its nucleic acid probe diagnostic assay for the direct quantification of...

Autologous immunotherapy shown safe, effective.
November 6, 2002... 2002 NOV 6 - (NewsRx.com & NewsRx.net) -- A clinical trial by researchers at the University of Medicine and Dentistry of New Jersey (UMDNJ) has shown a new autologous immunotherapy appears to be safe and effective treatment for controlling HIV....

Protease inhibitors compared in treatment-naive HIV/AIDS patients.
November 6, 2002... 2002 NOV 6 - (NewsRx.com & NewsRx.net) -- A study presented at the 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in San Diego, California, showed that a regimen containing the investigational protease inhibitor...

UMBI licenses HIV rat to Harlan.
November 6, 2002... 2002 NOV 6 - (NewsRx.com & NewsRx.net) -- The patent for the first HIV-1 transgenic rat model has been licensed to Harlan Sprague Dawley, Inc., by the University of Maryland Biotechnology Institute. Scientists at the UMBI's Institute of...

One day, nanotechnology could be used to track and kill cancer cells.
November 6, 2002... 2002 NOV 6 - (NewsRx.com & NewsRx.net) -- A new, patented nanotechnology that one day may allow cancer patients to receive treatments through an MRI procedure in a doctor's office is being developed by scientists at the University at Buffalo's...

DNA/RNA testing systems manufacturer elects Cynthia L. Sullivan to board of directors.
November 6, 2002... 2002 NOV 6 - (NewsRx.com & NewsRx.net) -- Digene Corporation (NASDAQ:DIGE) announced that Cynthia L. Sullivan has been elected by the directors to serve on the Board of Directors of Digene. Sullivan is also a nominee for election as a director...

DTI-015 developer completes enrollment of phase I/II trial of the new drug.
November 6, 2002... 2002 NOV 6 - (NewsRx.com & NewsRx.net) -- Direct Therapeutics, Inc., a privately held drug development company, announced that it has concluded patient enrollment and treatment for its multicenter phase I/II study of DTI-015, a new...

New fund formed to create and build new life science companies.
November 6, 2002... 2002 NOV 6 - (NewsRx.com & NewsRx.net) -- 5AM Ventures announced its establishment as a new fund focused on investing in seed and early-stage life science companies. The fund closed a $25 million round of financing split evenly between Bay...

Cancer treatment developer names CFO, strengthens board of directors.
November 6, 2002... 2002 NOV 6 - (NewsRx.com & NewsRx.net) -- ARC Pharmaceuticals, Inc., announced the appointment of Bruce Hay to the position of CFO. Hay, William Adams, and Dr. Jerry Gray have also been appointed to the board of directors. "We are pleased...

James W. Haney named vice president, manufacturing, distribution.
November 6, 2002... 2002 NOV 6 - (NewsRx.com & NewsRx.net) -- AVVAA World Health Care Products, Inc., (AVVW) announced James W. Haney has been named vice president, manufacturing and distribution for the corporation. Haney has over 30 years experience in all...

Cell-based product developer receives $0.9 million immune system research grant from DARPA.
November 6, 2002... 2002 NOV 6 - (NewsRx.com & NewsRx.net) -- Aastrom Biosciences, Inc., (ASTM) announced that it was awarded approximately $897,000 of a collaborative grant by the Defense Advanced Research Projects Agency (DARPA) providing funding over an...

FDA approves inclusion of gene test in Herceptin labeling.
November 6, 2002... 2002 NOV 6 - (NewsRx.com & NewsRx.net) -- Abbott Laboratories (ABT) anticipates that more breast cancer patients will benefit from use of its Vysis PathVysion fluorescence in situ hybridization (FISH) test as a result of the U.S. Food and Drug...

SpectRx receives $1 million milestone for glucose monitoring program.
November 6, 2002... 2002 NOV 6 - (NewsRx.com & NewsRx.net) -- SpectRx, Inc., (SPRX) announced that Abbott Laboratories (ABT) has agreed to make a $1 million milestone payment under a program to commercialize SpectRx's continuous glucose monitoring technology for...

Acadia discovers small molecule lead chemistries for V2 vasopressin receptor.
November 6, 2002... 2002 NOV 6 - (NewsRx.com & NewsRx.net) -- Acadia Pharmaceuticals announced the discovery of small molecule lead chemistries for the V2 Vasopressin receptor. The V2 Vasopressin receptor is the major control mechanism for the production of...

Zentaris inks agreement with oncology-focused company for oral signal transduction modulator.
November 6, 2002... 2002 NOV 6 - (NewsRx.com & NewsRx.net) -- Access Oncology, Inc., of New York City announced at the Bear Stearns Healthcare Conference that it has entered into a definitive license agreement with Zentaris AG of Frankfurt, Germany to develop...

Data reported from preclinical DACH platinum study in mice.
November 6, 2002... 2002 NOV 6 - (NewsRx.com & NewsRx.net) -- Access Pharmaceuticals, Inc. (AKC) reported data at the 2nd International Symposium on Tumor Targeted Delivery Systems indicating its experimental compound, AP5346, in the B16 murine melanoma model,...

Vitamin-mediated tumor targeting data confirm enhanced drug uptake.
November 6, 2002... 2002 NOV 6 - (NewsRx.com & NewsRx.net) -- Access Pharmaceuticals, Inc. (AKC) presented at the 2nd International Symposium on Tumor Targeted Delivery Systems in vitro and in vivo data on vitamin targeted polymers. Linking drugs to polymers...

Compounds selectively target zinc finger protein specific to HIV in vitro.
November 6, 2002... 2002 NOV 6 - (NewsRx.com & NewsRx.net) -- Achillion Pharmaceuticals announced the development of a new class of compounds that inhibits a broad spectrum of drug-resistant HIV strains by targeting a novel virus protein. ACH-0100703, a...

Data demonstrate potent antiviral activity of new anti-HBV agent.
November 6, 2002... 2002 NOV 6 - (NewsRx.com & NewsRx.net) -- An L-nucleoside antiviral agent, administered orally once daily, rapidly produced potent antihepatitis B virus (HBV) activity in patients chronically infected with HBV, reported Beth Israel Deaconess...

Nutraceutical company finalizes agreements for conversion of debt.
November 6, 2002... 2002 NOV 6 - (NewsRx.com & NewsRx.net) -- Advanced Nutraceuticals, Inc., (ANII), announced that it has reached agreements to convert $1,562,440 of convertible notes payable to directors and their affiliates, otherwise scheduled to mature during...

Biopharmaceutical firm raises $3M.
November 6, 2002... 2002 NOV 6 - (NewsRx.com & NewsRx.net) -- Advanced Viral Research Corp. (ADVR) announced the completion of a $3 million institutional financing transaction that enables the clinical studies of Product R in Israel to move forward. The...

Dr. Sidney Pestka joins ADVR scientific advisory board.
November 6, 2002... 2002 NOV 6 - (NewsRx.com & NewsRx.net) -- Advanced Viral Research Corp. (ADVR) announced that Dr. Sidney Pestka has joined the company's scientific advisory board. Pestka, a recipient of the National Medal of Technology, brings decades...

Steve Lombardi named VP of corporate development.
November 6, 2002... 2002 NOV 6 - (NewsRx.com & NewsRx.net) -- Affymetrix, Inc., (AFFX), announced the appointment of Steve Lombardi as vice president of Corporate Development. In this position, Lombardi will help Affymetrix build corporate value by working to...

Pharmaceutical company completes $45 million private placement.
November 6, 2002... 2002 NOV 6 - (NewsRx.com & NewsRx.net) -- Alexza MDC, a specialty pharmaceutical company developing products with faster onset of therapeutic effect, closed on its first round of institutional financing. This first institutional round of...

Company updates RSR13 phase II study results.
November 6, 2002... 2002 NOV 6 - (NewsRx.com & NewsRx.net) -- Allos Therapeutics, Inc., (ALTH) announced updated positive survival results from a phase II clinical trial evaluating the use of RSR13 (efaproxiral) in patients with locally advanced, unresectable,...

Company opens U.S. headquarters in New Jersey, names VP of sales and marketing.
November 6, 2002... 2002 NOV 6 - (NewsRx.com & NewsRx.net) -- The U.S. operations of German-based Altana Pharma, AG, the pharmaceutical division of Altana, AG, (AAA), officially opened its late-stage development and marketing headquarters in New Jersey. ...

Collaboration to study controlled release, targeted delivery of oral medicines.
November 6, 2002... 2002 NOV 6 - (NewsRx.com & NewsRx.net) -- Amarin Corporation plc (NASDAQ:AMRN) announced that its Swedish subsidiary, Amarin Development AB, has entered into a research collaboration with CellGate Inc. to assess the feasibility of improving...

Margie Nemcik-Cruz named VP of neurology-, pain-focused pharmaceutical company.
November 6, 2002... 2002 NOV 6 - (NewsRx.com & NewsRx.net) -- Amarin Corp., plc, (AMRN) announced the appointment of Margie Nemcik-Cruz as vice president, regulatory affairs of Amarin Pharmaceuticals, Inc., its U.S. drug development and marketing subsidiary. ...

Licensing agreement reached with Celera Diagnostics.
November 6, 2002... 2002 NOV 6 - (NewsRx.com & NewsRx.net) -- Ambion RNA Diagnostics, a division of Ambion, Inc., announced that it has granted Celera Diagnostics, a joint venture between the Applied Biosystems Group (ABI) and the Celera Genomics Group (CRA) of...

Grant awarded to advance RNA interference technology used for gene analysis.
November 6, 2002... 2002 NOV 6 - (NewsRx.com & NewsRx.net) -- Ambion, Inc. (Austin, Texas, has been awarded a phase I SBIR grant valued at $221,000 from the U.S. National Institute of General Medical Sciences (NIGMS) to further the development of short interfering...

New Internet protocol used successfully for ultra-telephonic stethoscope.
November 6, 2002... 2002 NOV 6 - (NewsRx.com & NewsRx.net) -- American TeleCare, Inc. (ATI) announced the successful development and market introduction of a software program for transporting CareTone Ultra Digital Tele-Stethoscope signal over IP (Internet...

Data submitted to FDA supporting use of Enbrel.
November 6, 2002... 2002 NOV 6 - (NewsRx.com & NewsRx.net) -- Amgen (NASDAQ:AMGN) announced that it has submitted a supplemental Biologics License Application (sBLA) with the U.S. Food and Drug Administration (FDA) for the use of Enbrel (etanercept) to improve...

Angiotech announces agreement to acquire Cohesion Technologies, Inc.
November 6, 2002... 2002 NOV 6 - (NewsRx.com & NewsRx.net) -- Angiotech Pharmaceuticals, Inc. (NASDAQ:ANPI; TSX:ANP) and Cohesion Technologies, Inc. (NASDAQ:CSON) jointly announced that they have signed a definitive agreement for Angiotech to acquire Cohesion in...

Efficacy trials will assess prophylactic and therapeutic indications.
November 6, 2002... 2002 NOV 6 - (NewsRx.com & NewsRx.net) -- Antex Biologics, Inc. (ANX) has announced that two phase II trials for its Helivax vaccine against Helicobacter pylori are scheduled to begin next quarter. One trial will assess the preventative...

Automated imaging company releases new clinical system.
November 6, 2002... 2002 NOV 6 - (NewsRx.com & NewsRx.net) -- Applied Imaging Corp. (AICX) announced the release of Ariol, the company's latest cellular imaging system. Ariol is a high-throughput system designed to automate and standardize the analysis of...

Collaboration will evaluate aerosol delivery platform for gene drug compounds.
November 6, 2002... 2002 NOV 6 - (NewsRx.com & NewsRx.net) -- Aradigm Corporation (NASDAQ:ARDM) and geneRx+, an innovator in protein and gene-based technologies, announced a joint collaboration to study the feasibility of pulmonary delivery of geneRx+'s two lead...

Company gets FDA OK to include superiority data on Atacand label.
November 6, 2002... 2002 NOV 6 - (NewsRx.com & NewsRx.net) -- AstraZeneca announced that the U.S. Food and Drug Administration (FDA) has approved the inclusion in labeling of data from a clinical trial program showing that AstraZeneca's angiotensin II receptor...

Phase III data confirm Seroquel in combination with mood stabilizer is effective.
November 6, 2002... 2002 NOV 6 - (NewsRx.com & NewsRx.net) -- AstraZeneca announced that data from the first in a series of phase III trials demonstrate that the combination of Seroquel (quetiapine) and mood stabilizer is significantly more effective than mood...

Phase I clinical trial results reported for antirejection drug.
November 6, 2002... 2002 NOV 6 - (NewsRx.com & NewsRx.net) -- AtheroGenics, Inc. (NASDAQ:AGIX), a pharmaceutical company focused on the treatment of chronic inflammatory diseases, announced positive results from a phase I clinical trial that assessed the safety...

Judy H. Chiao, MD, named VP, oncology clinical R&D of drug discovery company.
November 6, 2002... 2002 NOV 6 - (NewsRx.com & NewsRx.net) -- Aton Pharma, Inc., a privately held biopharmaceutical company with the mission to discover and develop therapeutics for cancer and other diseases, announced that Judy H. Chiao, MD, has been promoted to...

Drug delivery firm submits two abbreviated new drug applications to FDA.
November 6, 2002... 2002 NOV 6 - (NewsRx.com & NewsRx.net) -- Atrix Laboratories, Inc., (ATRX) announced that the company has submitted two abbreviated new drug applications (ANDAs) to the U.S. Food and Drug Administration (FDA) for approval of generic...

New company offers personalized care via predictive pathology.
November 6, 2002... 2002 NOV 6 - (NewsRx.com & NewsRx.net) -- A new biotechnology company, privately held Aureon Biosciences, offers a technology platform that predicts individual clinical outcomes by interrogating and analyzing tissue to provide the first...

Investigational new drug applications filed for M-Vax, O-Vax.
November 6, 2002... 2002 NOV 6 - (NewsRx.com & NewsRx.net) -- Avax Technologies, Inc., (AVXT) announced the submission of investigational new drug applications (IND) for M-Vax and O-Vax, its AC Vaccine technology product candidates for the treatment of melanoma...

HHS announces contracts for developing new vaccine.
November 6, 2002... 2002 NOV 6 - (NewsRx.com & NewsRx.net) -- U.S. Department of Health and Human Services (HHS) Secretary Tommy G. Thompson has announced that the National Institute of Allergy and Infectious Diseases (NIAID) has awarded two companies contracts...

FDA approves preservative-free flu vaccine for pediatric use.
November 6, 2002... 2002 NOV 6 - (NewsRx.com & NewsRx.net) -- Aventis Pasteur announced the U.S. Food and Drug Administration (FDA) has approved licensure to market Fluzone Preservative-free: Pediatric Dose, Influenza Virus Vaccine. For the first time,...

Biochip company announces $11.8 million series B financing.
November 6, 2002... 2002 NOV 6 - (NewsRx.com & NewsRx.net) -- Aviva Biosciences Corporation, a privately held biochip company focused on cellular screening and analysis, announced the first closing of $11.8 million through a series B financing. This funding...

Wilding assumes role as chairman of the board.
November 6, 2002... 2002 NOV 6 - (NewsRx.com & NewsRx.net) -- Aviva Biosciences Corporation, a developer of biochip technologies for drug discovery and diagnostics, announced the appointment of Norrie Russell, PhD, as president and CEO. Russell succeeds Peter...

Company to challenge FDA delay of manufactured tamoxifen launch.
November 6, 2002... 2002 NOV 6 - (NewsRx.com & NewsRx.net) -- Barr Laboratories, Inc., (BRL) has announced that it disagrees with a letter, received from the U.S. Food and Drug Administration (FDA), which retroactively alters the approval date of Barr's...

NDA accepted for filing by FDA for extended-regimen oral contraceptive.
November 6, 2002... 2002 NOV 6 - (NewsRx.com & NewsRx.net) -- Barr Laboratories, Inc., (BRL) announced that the U.S. Food and Drug Administration (FDA) has accepted for review the company's new drug application (NDA) for its Seasonale extended regimen oral...

Customers advised to suspend use of certain bloodlines pending investigation.
November 6, 2002... 2002 NOV 6 - (NewsRx.com & NewsRx.net) -- Baxter Healthcare Corporation has been notified that four patients died over a 1-2 week period after receiving dialysis treatment at a hemodialysis center in Mishawauka, Indiana. The investigation...

FDA clearance granted for blood collection system.
November 6, 2002... 2002 NOV 6 - (NewsRx.com & NewsRx.net) -- Baxter Healthcare Corporation received clearance from the U.S. Food and Drug Administration (FDA) for a fast, portable, automated blood collection system that offers the potential to increase the supply...

Enhanced tamper-resistant packaging introduced by Bayer.
November 6, 2002... 2002 NOV 6 - (NewsRx.com & NewsRx.net) -- Bayer Biological Products (BP) has introduced enhanced tamper-resistant packaging in response to recent concerns about product tampering. The roll-out of seal tabs on all boxes containing Gamimune...

Study shows Levitra offers consistent results for most men.
November 6, 2002... 2002 NOV 6 - (NewsRx.com & NewsRx.net) -- Bayer Corporation reported study results showing that the majority of men with erectile dysfunction (ED) who were taking the oral investigational drug Levitra (vardenafil HCl) reported improved erectile...

NIH intended for development of oral prophylactic/therapeutic HIV vaccine.
November 6, 2002... 2002 NOV 6 - (NewsRx.com & NewsRx.net) -- BioDelivery Sciences International (BDSI; BDSIW) announced that they have received a 2-year $600,000 National Institutes of Health (NIH) SBIR Grant to develop an oral form of a powerful HIV...

BLA for Aldurazyme accepted by FDA, granted priority review status.
November 6, 2002... 2002 NOV 6 - (NewsRx.com & NewsRx.net) -- BioMarin Pharmaceutical, Inc., (BMRN) and Genzyme General (GENZ) announced that the U.S. Food and Drug Administration (FDA) has accepted for review their biologics license application (BLA) filing for...

Stockholder rights plan adopted.
November 6, 2002... 2002 NOV 6 - (NewsRx.com & NewsRx.net) -- BioMarin Pharmaceutical, Inc., (BMRN) announced that its board of directors has adopted a stockholder rights plan. BioMarin adopted the plan in order to better protect stockholders and assure that...

CRO announces services agreement with MedImmune.
November 6, 2002... 2002 NOV 6 - (NewsRx.com & NewsRx.net) -- BioReliance Corp. (BREL) announced that it has entered into a laboratory services agreement with MedImmune, Inc. Under the agreement, BioReliance will perform a range of assays for certain of...

$4.5M raised in self-underwritten public offering by BioSante.
November 6, 2002... 2002 NOV 6 - (NewsRx.com & NewsRx.net) -- BioSante Pharmaceuticals, Inc., (BISP) announced that it has raised $4,500,000 in a self-underwritten, best efforts public offering under a registration statement filed with the Securities and Exchange...

Extended patent approval granted for AM500 antimicrobial.
November 6, 2002... 2002 NOV 6 - (NewsRx.com & NewsRx.net) -- BioShield Technologies, Inc., (BSTI) has recently received from the U.S. Patent Office an approval extending BioShield's AM500 antimicrobial, securing the rights to a broader array of applications and...

Reorganization will support corporate restructuring.
November 6, 2002... 2002 NOV 6 - (NewsRx.com & NewsRx.net) -- BioShield Technologies, Inc., (BSTI) announced that they have reorganized the team to support overall cost reductions and operating expenses. Deirdre Baker stated, "We are aligning our manpower...

Amevive application on track for early 2003 approval.
November 6, 2002... 2002 NOV 6 - (NewsRx.com & NewsRx.net) -- Biogen, Inc., (BGEN) announced that the Food and Drug Administration (FDA) has committed to complete the review of its Amevive (alefacept) application within 6 months. After review of the...

Japanese patent granted on miniaturization device.
November 6, 2002... 2002 NOV 6 - (NewsRx.com & NewsRx.net) -- Biolog, Inc., announced that it has received another patent on its proprietary miniaturization technology. This technology is applicable to the company's MicroLog microbiology...

First animal model of inherited human epilepsy created.
November 6, 2002... 2002 NOV 6 - (NewsRx.com & NewsRx.net) -- Bionomics announced a major breakthrough for epilepsy sufferers with the creation of the world's first animal model of inherited human epilepsy. Bionomics has developed a mouse model that exhibits...

Antibiotic maker awarded a EUR 6.5 million grant.
November 6, 2002... 2002 NOV 6 - (NewsRx.com & NewsRx.net) -- Biosearch Italia SpA (BIO.MI) announced that it has been awarded a EUR 6.5 million Innovation Technology Fund (FIT) grant by the Italian Ministry of Productive Activities (MAP), to support preclinical...

Spiriva gets recommendation for approval by FDA committee.
November 6, 2002... 2002 NOV 6 - (NewsRx.com & NewsRx.net) -- Boehringer Ingelheim Pharmaceuticals, Inc., said that an Advisory Committee to the U.S. Food and Drug Administration recommended approval of Spiriva (tiotropium bromide inhalation powder) for the...

FDA approves Express2 coronary stent system.
November 6, 2002... 2002 NOV 6 - (NewsRx.com & NewsRx.net) -- Boston Scientific Corporation (BSX) announced that it has received premarket approval (PMA) from the U.S. Food and Drug Administration (FDA) to market its Express2 coronary stent system. The...

Health activists, AIDS suffers in Thailand file suit to dislodge patent on HIV drug.
November 6, 2002... 2002 NOV 6 - (NewsRx.com & NewsRx.net) -- Wanting cheaper treatment for Thailand's estimated 1 million HIV/AIDS sufferers, people with the disease and consumer activists on October 9, 2002, filed a lawsuit to invalidate a drug patent held here...

Calypte Biomedical highlights its rapid HIV urine test at conference.
November 6, 2002... 2002 NOV 6 - (NewsRx.com & NewsRx.net) -- Calypte Biomedical Corporation (CALY), the developer and marketer of the only two U.S. Food and Drug Administration (FDA) approved HIV-1 antibody tests for use with urine samples, shared information...

Urine HIV-1 antibody test approved for life insurance screening.
November 6, 2002... 2002 NOV 6 - (NewsRx.com & NewsRx.net) -- Calypte Biomedical Corp. (CALY) , the developer and marketer of the only two FDA-approved HIV-1 antibody tests that can be used on urine samples, announced that the West Virginia Office of the Insurance...

Biotech company begins two projects in Canadian preparedness initiative.
November 6, 2002... 2002 NOV 6 - (NewsRx.com & NewsRx.net) -- Cangene announced that it will undertake two research and technology projects as part of an initiative aimed at improving Canada's readiness in the event of chemical, biological, radiological, or...

Immunotherapeutic compound to be tested in animal model.
November 6, 2002... 2002 NOV 6 - (NewsRx.com & NewsRx.net) -- Cel-Sci Corporation (CVM) announced an agreement with the Cincinnati Children's Hospital Medical Center (CHMR) of the University of Cincinnati, Ohio, to evaluate Cel-Sci's new compound CEL-1000...

Newly discovered peptide induces protection against malaria.
November 6, 2002... 2002 NOV 6 - (NewsRx.com & NewsRx.net) -- Cel-Sci Corporation (CVM) responded to requests on the status of its malaria program following the local announcement that two Northern Virginia teenagers contracted malaria even though they have not...

Parasite, mosquito genomes complete malaria picture.
November 6, 2002... 2002 NOV 6 - (NewsRx.com & NewsRx.net) -- Genome sequences of Plasmodium falciparum, the most lethal malaria-causing parasite, and Anopheles gambiae, a mosquito that transmits the parasite to humans, are now complete, two international research...

Skeletex successfully induces new bone formation.
November 6, 2002... 2002 NOV 6 - (NewsRx.com & NewsRx.net) -- CellFactors plc said its novel human cell-derived bone-regeneration product Skeletex has successfully demonstrated its ability to induce the spontaneous formation of new bone. These positive...

Additional phase III trials required by FDA for Cellegesic.
November 6, 2002... 2002 NOV 6 - (NewsRx.com & NewsRx.net) -- Cellegy Pharmaceuticals, Inc., (CLGY) announced that the FDA will require the company to conduct an additional phase III clinical trial in order to obtain approval of Cellegesic (nitroglycerin ointment)...

Cellegesic study results published.
November 6, 2002... 2002 NOV 6 - (NewsRx.com & NewsRx.net) -- Cellegy Pharmaceuticals, Inc., (CLGY) announced that in the journal Diseases of the Colon & Rectum (2002;45(9)) peer reviewed results were reported from its first phase III trial using Cellegesic...

Advanced BioApplication software module launched.
November 6, 2002... 2002 NOV 6 - (NewsRx.com & NewsRx.net) -- Cellomics, Inc., the pioneer of High Content Screening (HCS), announced the launch of their advanced Compartmental Analysis HCS BioApplication software. Compartmental analysis (CA) is a flexible,...

Manufacturing, supply agreement struck with Biochemie.
November 6, 2002... 2002 NOV 6 - (NewsRx.com & NewsRx.net) -- Celltech Group plc (CLL) announced that it has entered into a long-term agreement with Biochemie, an affiliate of Novartis AG (NVS), under which Biochemie will manufacture for and supply to Celltech...

David Brown named president, CEO.
November 6, 2002... 2002 NOV 6 - (NewsRx.com & NewsRx.net) -- Cellzome AG announced that it has appointed David Brown, PhD, to the position of president and CEO. Brown succeeds Charles Cohen, PhD, who will now serve as chairman of the company's supervisory board....

Positive results from a Provigil ADHD study announced.
November 6, 2002... 2002 NOV 6 - (NewsRx.com & NewsRx.net) -- Cephalon, Inc., (CEPH) announced results from an investigational, multicenter clinical study in 248 children between ages 6-13. The results of the study show that Provigil (modafinil) tablets...

Chemicon International launches new tissue array instrument.
November 6, 2002... 2002 NOV 6 - (NewsRx.com & NewsRx.net) -- Chemicon International, Inc., a leading provider of immunological and molecular biology reagents and tests, announced the launch of the ATA100 Advanced Tissue Arrayer. The ATA100 provides...